🇺🇸 FDA
Pipeline program

Influenza Virus Vaccine

CSLCT-FLU-04-05

Phase 3 mab completed

Quick answer

Influenza Virus Vaccine for Influenza is a Phase 3 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Seqirus (Australia) Pty Ltd
Indication
Influenza
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials